Krill Oil
Natural health product licensed in Canada
- Other names
- Viva Naturals Krill Oil
- Licence holder
- Viva Naturals Inc.
- NPN or DIN-HM
- 80062242
- Status
- Inactive licence
- Licence date
- 25 June 2015
- Revision date
- 26 March 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de krill Source : Euphausia superba - en entier Potency : 287.5 milligramme Phospholipids | 625 milligramme | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 0.8 milligramme Esterified astaxanthin | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 165 milligramme Omega-3 Fatty acids | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 45 milligramme Docosahexaenoic acid | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 90 milligramme Eicosapentaenoic acid | Not specified | Not calculated |
Non-medicinal ingredients
Gélatine, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Helps to relieve symptoms of dysmenorrhea and premenstrual syndrome. Helps to relieve symptoms of premenstrual syndrome. Helps to maintain cardiovascular health. Helps to reduce serum triglycerides/triacylglycerols in conjunction with conventional statin therapy. Helps to reduce the levels of LDL cholesterol in conjunction with conventional statin therapy. Helps to increase the levels of HDL cholesterol in conjunction with conventional statin therapy. Helps to reduce pain associated with osteoarthritis. Helps to reduce C reactive protein levels, a clinical marker of inflammation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur with shellfish; if this occurs, discontinue use.
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80062242
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.